Stifel Financial Corp Recursion Pharmaceuticals, Inc. Transaction History
Stifel Financial Corp
- $99.8 Billion
- Q2 2025
A detailed history of Stifel Financial Corp transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Stifel Financial Corp holds 256,092 shares of RXRX stock, worth $1.71 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
256,092
Previous 187,259
36.76%
Holding current value
$1.71 Million
Previous $990,000
30.81%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding RXRX
# of Institutions
368Shares Held
290MCall Options Held
7.76MPut Options Held
6.19M-
Vanguard Group Inc Valley Forge, PA36.1MShares$241 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl33MShares$220 Million1.38% of portfolio
-
Baillie Gifford & CO24.2MShares$161 Million0.1% of portfolio
-
Black Rock Inc. New York, NY17.3MShares$116 Million0.0% of portfolio
-
Softbank Group Corp Minato Ku Tokyo, M014.7MShares$98 Million0.31% of portfolio
About RECURSION PHARMACEUTICALS, INC.
- Ticker RXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 180,480,000
- Market Cap $1.21B
- Description
- Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...